ReviewMolecules (Basel, Switzerland)2022

Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder.

Mohammed Moutaz Nakhal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.